Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Control Trial Comparing Peginterferon-α-2a Versus Observation After Stopping Tyrosine Kinase Inhibitor in Chronic Myeloid Leukemia With Deep Molecular Response for at Least Two Years

NCT02381379 is registered in ClinicalTrials.gov with Ministry of Health, Malaysia as lead sponsor.

NCT NCT02381379
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02381379 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Control Trial Comparing Peginterferon-α-2a Versus Observation After Stopping Tyrosine Kinase Inhibitor in Chronic Myeloid Leukemia With Deep Molecular Response for at Least Two Years
Lead sponsor
Ministry of Health, Malaysia
Phase
Phase 3
Overall status
Unknown status
Start date
March 31, 2015
Completion date
October 31, 2021
Enrollment
118 (estimated)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

leukemia, chronic myeloid